bioAffinity Technologies, Inc.
Price Action
Technical Summary
WEAKENINGbioAffinity Technologies, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is leading (RS Rating: 88), indicating clear outperformance against the broad market. Earnings growth of 1% provides fundamental context to the price action. Investors should exercise caution due to high volatility (212% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $2.53 | -16.05% | BELOW |
| 50 SMA | $2.58 | -17.99% | BELOW |
| 100 SMA | $1.89 | +12.13% | ABOVE |
| 150 SMA | $1.98 | +7.05% | ABOVE |
| 200 SMA | $3.34 | -36.47% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is BIAF in an uptrend right now?
BIAF has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is BIAF overbought or oversold?
BIAF's RSI (14) is 38. The stock is in neutral territory, neither overbought nor oversold.
Is BIAF outperforming the market?
BIAF has a Relative Strength (RS) Rating of 88 out of 99. Yes, BIAF is a market leader, outperforming 88% of all stocks over the past 12 months.
Where is BIAF in its 52-week range?
BIAF is trading at $2.12, which is 14% of its 52-week high ($15.00) and 10% above its 52-week low ($0.69).
How volatile is BIAF?
BIAF has a Beta of 2.53 and 52-week volatility of 212%. It's more volatile than the S&P 500 - expect bigger swings.